Fiammetta Vanoli
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Disease changes and cost analysis of myasthenia gravis: a 10 years retrospective study from a reference center in Italy.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: January 30, 2026
Enhanced antibody detection via live cell-based assay among RIA negative myasthenia gravis patients: toward improved diagnosis and clinical correlates.
Journal: Journal of neurology
Published: January 16, 2026
Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study.
Journal: Journal of the neurological sciences
Published: October 06, 2025
Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis: A New Mechanism of Action Beyond IgG Reduction.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 31, 2025
278th ENMC International Workshop: European standards for harmonization of myasthenia gravis registries and emerging digital solutions. 20th-21st September 2024, Hoofddorp, The Netherlands.
Journal: Neuromuscular disorders : NMD
Published: April 14, 2025
Efgartigimod improves non-AChR generalized Myasthenia Gravis: a real world experience.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: November 24, 2024
Toward European harmonization of national myasthenia gravis registries: modified Delphi procedure-based expert consensus on collectable data.
Journal: Orphanet journal of rare diseases
Published: October 22, 2024
Caregiving burden among caregivers of people with myasthenia gravis.
Journal: Orphanet journal of rare diseases
Published: February 28, 2024
Efgartigimod improves triple-negative myasthenia gravis.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: September 15, 2023
Current drug treatment of myasthenia gravis.
Journal: Current opinion in neurology
Published: September 07, 2023
Efgartigimod in generalized myasthenia gravis: A real-life experience at a national reference center.
Journal: European journal of neurology
Published: June 06, 2023
Reply to: intravenous immunoglobulin (Gamunex® 10%) is licensed for the treatment of severe acute exacerbations of myasthenia gravis.
Journal: Expert opinion on pharmacotherapy
Published: April 14, 2023
Last Updated: 09/26/2026